Paper Summary
Paperzilla title
Bye Bye Bitter Medicine: Nano-Sponges Make Griseofulvin Taste-Free for Kids!
This study developed a cyclodextrin-based nanosponge formulation of griseofulvin that significantly improved drug dissolution, enhanced bioavailability in rats, and effectively masked the bitter taste in a human panel. This approach offers a potential solution for pediatric oral liquid formulations of griseofulvin.
Possible Conflicts of Interest
None identified
Identified Weaknesses
The study acknowledges the need for further in vivo absorption studies in humans and clinical investigations in patients to support the obtained results, indicating a lack of human data.
Limited Generalizability to Humans
The study relies on in vitro and in vivo rat data, which may not fully translate to human outcomes. The formulation's effectiveness in humans remains to be confirmed.
Small Sample Size for Taste Masking
While taste masking was evaluated with a human panel, the sample size is small (n=6), potentially limiting the reliability of the findings.
Lack of Long-Term Stability and Scalability Data
The formulation's long-term stability and potential for large-scale manufacturing are not addressed in the study.
Rating Explanation
This study demonstrates a promising approach to enhance the bioavailability and mask the bitter taste of griseofulvin, a crucial factor for pediatric formulations. The methodology is generally sound, including in vitro and in vivo experiments, but the lack of human data and limited generalizability are notable weaknesses.
Good to know
This is our free standard analysis. Paperzilla Pro fact-checks every citation, researches author backgrounds and funding sources, and uses advanced AI reasoning for more thorough insights.
File Information
Original Title:
Formulation and evaluation of cyclodextrin-based nanosponges of griseofulvin as pediatric oral liquid dosage form for enhancing bioavailability and masking bitter taste
Uploaded:
July 14, 2025 at 10:54 AM
© 2025 Paperzilla. All rights reserved.